Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


Med Ad News Insider

Archive for August, 2010

Concentric handles Solesta promotion

Monday, August 30th, 2010

Concentric Pharma Advertising is tapped to market Oceana Therapeutics Inc.’s Solesta as domestic agency of record. The agency is designing online and offline campaigns for the fecal incontinence device, which target physician and consumer audiences across the print and online media. Solesta is expected to launch in the first half ...

Core Create’s Camp Adventure Campaign Inspires and Informs

Wednesday, August 18th, 2010

Core-Create’s awareness campaign for the American Cancer Society’s Camp Adventure prescribes healthy doses of whimsy and courage. Camp Adventure 2010 is a week-long, sleep-away camp for children with cancer and their siblings, held on the shores of Shelter Island, N.Y. The camp began August 14 and continues through August 20. “As ...

Roche’s social media rules

Tuesday, August 17th, 2010

It was bound to happen eventually. Our friends at Roche have posted their very own company social media rules. Or, rather, the "Roche Social Media Principles." I don't recall ever seeing what looks like internal corporate social media rules and regs posted in a public place like this. Doesn't mean it ...

Celebrities and pharmaceuticals 101

Friday, August 13th, 2010

We get lots of press releases here, hundreds each day, and after a while many of them start to look the same. So imagine my surprise yesterday when this headline landed in my inbox: The Cure for the Common Celebrity Search:  Rx Entertainment New Agency Focused on the Healthcare Entertainment Marketing This ...

A ray of hope out of Tasigna DDMAC letter

Friday, August 6th, 2010

At first glance, the letter from FDA's DDMAC about Novartis' Facebook Share widget for the cancer drug Tasigna seems to be a case of the regulatory agency being digitally backward. But not so, says Bruce Grant, senior VP of business strategy at Digitas Health. He argues that FDA wasn't making a ...